Retractable Technologies, Inc.  

(Public, NYSEMKT:RVP)   Watch this stock  
Find more results for NYSEAMEX:RVP
0.00 (0.00%)
Feb 5 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 2.78 - 2.87
52 week 2.56 - 5.70
Open 2.85
Vol / Avg. 23,820.00/16,250.00
Mkt cap 78.10M
P/E 16.61
Div/yield     -
EPS 0.17
Shares 27.89M
Beta 0.86
Inst. own 6%
Mar 30, 2016
Q4 2015 Retractable Technologies Inc Earnings Release (Estimated) Add to calendar
Nov 17, 2015
Q3 2015 Retractable Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -2.69% -6.82%
Operating margin -2.10% -6.25%
EBITD margin - -3.14%
Return on average assets -2.38% -4.99%
Return on average equity -6.20% -12.17%
Employees 130 -
CDP Score - -


511 Lobo Lane
LITTLE ELM, TX 75068-0009
United States - Map
+1-972-2941010 (Phone)
+1-972-2923600 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Retractable Technologies, Inc. designs, develops, manufactures and safety syringes and other safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. VanishPoint products are designed to prevent needle stick injuries. VanishPoint safety products consist of tuberculin, insulin and allergy antigen VanishPoint syringes; two milliliters, three milliliters, five milliliters, and 10 milliliters VanishPoint syringes; and the VanishPoint autodisable syringe. The Company also sells the VanishPoint IV catheter, the VanishPoint blood collection tube holder, and the VanishPoint blood collection set. The PatientSafe syringe embodies a patented design and protects patients by reducing the risk of bloodstream infections resulting from catheter hub contamination. PatientSafe syringe products consist of PatientSafe syringes and the PatientSafe Luer cap.

Officers and directors

Thomas J. Shaw Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas W. Cowan Chief Financial Officer, Vice President, Principal Accounting Officer, Treasurer, Director
Age: 72
Bio & Compensation  - Reuters
Michele M. Larios Vice President, General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
Russell B. Kuhlman Vice President - Sales
Age: 61
Bio & Compensation  - Reuters
Walter O. Bigby Jr. Independent Director
Age: 50
Bio & Compensation  - Reuters
Marco Laterza Independent Director
Age: 67
Bio & Compensation  - Reuters
Amy Mack Independent Director
Age: 47
Bio & Compensation  - Reuters